archetype (adl_version=1.4)
	openEHR-EHR-EVALUATION.heng_score_for_mrcc_assessment.v1

concept
	[at0000]	-- Heng score för prognos vid metastaserad njurcellscancer - utvärdering
language
	original_language = <[ISO_639-1::en]>
	translations = <
		["sv"] = <
			language = <[ISO_639-1::sv]>
			author = <
				["name"] = <"Dennis Forslund">
				["email"] = <"models@cambiocds.com">
				["organisation"] = <"Cambio Healthcare Systems">
			>
		>
	>
description
	original_author = <
		["name"] = <"Syeeda S Farruque">
		["email"] = <"models@cambiocds.com">
		["organisation"] = <"Cambio Healthcare Systems">
		["date"] = <"2017-08-30">
	>
	details = <
		["sv"] = <
			language = <[ISO_639-1::sv]>
			purpose = <"Att med objektiva mått beräkna en prognos av överlevnadsgrad bland patienter med metastastisk njurcellscancer som genomgått VEGF-behandling.">
			use = <"Använd som understöd vid stratifiering med avseende på överlevnadsgrad. Metoden är ännu inte validerad, men tre grupper med uppskattad medianöverlevnad har kunnat identifieras. Resultatet tolkas enligt:

≤1p - gynnsam prognos: 43.2 månader
2p - mellanliggande prognos: 22.5 månader
≥3p - dålig prognos : 7.8 månader">
			keywords = <"*metastatic renal cell carcinoma(en)", "*vascular endothelial growth factor(en)", "*Heng score for metastatic rcc prognosis(en)", "vaskulär endotelcellstillväxtfaktor", "vascular endothelial growth factor", "VEGF", "njurcellscancer", "njurcellscarcinom", "cancer", "heng score", "onkologi">
			misuse = <"Endast avsedd att utgöra understöd till klinisk bedömning då metoden ännu inte är validerad.">
			copyright = <"© Cambio Healthcare Systems">
		>
		["en"] = <
			language = <[ISO_639-1::en]>
			purpose = <"Provides an assessment of overall survival in mRCC (metastatic renal cell carcinoma) patients treated with VEGF (vascular endothelial growth factor)–targeted therapy.">
			use = <"Helps to roughly stratify patients with mRCC into 3 survival prognostic groups.

No validated scroing systems available for the prediciton of mRCC survival but there are three survival groups with associated median survival: 

Score interpretation:

Score 	Prognosis  	Median Survival
≤1 	Favorable  	43.2 months
2 	Intermediate 	22.5 months
≥3 	Poor 	                   7.8 months
">
			keywords = <"metastatic renal cell carcinoma", "vascular endothelial growth factor", "Heng score for metastatic rcc prognosis">
			misuse = <"Must be used with sound clinical judgment as validation of the tool is still to be completed.">
			copyright = <"© Cambio Healthcare Systems">
		>
	>
	lifecycle_state = <"AuthorDraft">
	other_contributors = <>
	other_details = <
		["references"] = <"Ref. 1: Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, Eigl BJ, Ruether JD, Cheng T, North S, Venner P, Knox JJ, Chi KN, Kollmannsberger C,McDermott DF, Oh WK, Atkins MB, Bukowski RM, Rini BI, Choueiri TK. Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study. JCO Dec 1, 2009:5794-5799; published online on October 13, 2009.">
		["MD5-CAM-1.0.1"] = <"5D955367A977413588F280417F630822">
	>

definition
	EVALUATION[at0000] matches {	-- Heng score för prognos vid metastaserad njurcellscancer - utvärdering
		data matches {
			ITEM_TREE[at0001] matches {	-- *Tree(en)
				items cardinality matches {0..*; unordered} matches {
					ELEMENT[at0002] occurrences matches {0..1} matches {	-- Prognos
						value matches {
							0|[local::at0004], 	-- Gynnsam
							1|[local::at0005], 	-- Mellanliggande
							2|[local::at0006]  	-- Dålig
						}
					}
					ELEMENT[at0003] occurrences matches {0..1} matches {	-- Överlevnad i snitt
						value matches {
							0|[local::at0007], 	-- 43.2 månader
							1|[local::at0008], 	-- 22.5 månader
							2|[local::at0009]  	-- 7.8 månader
						}
					}
				}
			}
		}
	}

ontology
	term_definitions = <
		["en"] = <
			items = <
				["at0000"] = <
					text = <"Heng score for mrcc assessment">
					description = <"Provides an assessment of overall survival in mRCC (metastatic renal cell carcinoma) patients treated with VEGF (vascular endothelial growth factor)–targeted therapy.">
				>
				["at0001"] = <
					text = <"Tree">
					description = <"@ internal @">
				>
				["at0002"] = <
					text = <"Prognosis">
					description = <"Prognosis">
				>
				["at0003"] = <
					text = <"Median Survival">
					description = <"Median survival">
				>
				["at0004"] = <
					text = <"Favorable">
					description = <"Score ≤1 ">
				>
				["at0005"] = <
					text = <"Intermediate">
					description = <"Score 2">
				>
				["at0006"] = <
					text = <"Poor">
					description = <"Score ≥3 ">
				>
				["at0007"] = <
					text = <"43.2 months">
					description = <"Score ≤1 ">
				>
				["at0008"] = <
					text = <"22.5 months">
					description = <"Score 2">
				>
				["at0009"] = <
					text = <" 7.8 months">
					description = <"Score ≥3 ">
				>
			>
		>
		["sv"] = <
			items = <
				["at0000"] = <
					text = <"Heng score för prognos vid metastaserad njurcellscancer - utvärdering">
					description = <"Ger understöd för bedömning av överlevnad bland patienter med metastastisk njurcellscancer som genomgått behandling inriktad mot vaskulär endotelcellstillväxtfaktor (VEGF).
">
				>
				["at0001"] = <
					text = <"*Tree(en)">
					description = <"*@ internal @(en)">
				>
				["at0002"] = <
					text = <"Prognos">
					description = <"">
				>
				["at0003"] = <
					text = <"Överlevnad i snitt">
					description = <"">
				>
				["at0004"] = <
					text = <"Gynnsam">
					description = <"≤1p">
				>
				["at0005"] = <
					text = <"Mellanliggande">
					description = <"2p">
				>
				["at0006"] = <
					text = <"Dålig">
					description = <"≥3p">
				>
				["at0007"] = <
					text = <"43.2 månader">
					description = <"≤1p">
				>
				["at0008"] = <
					text = <"22.5 månader">
					description = <"2p">
				>
				["at0009"] = <
					text = <"7.8 månader">
					description = <"≥3p">
				>
			>
		>
	>
